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SUMMARY
Direct transdifferentiation of somatic cells is a promising approach to obtain patient-specific cells for numerous applications. However,
conversion across germ-layer borders often requires ectopic gene expression with unpredictable side effects. Here, we present a gene-free
approach that allows efficient conversion of human fibroblasts via a transient progenitor stage into Schwann cells, the major glial cell
type of peripheral nerves. Using a multikinase inhibitor, we transdifferentiated fibroblasts into transient neural precursors that were sub-
sequently further differentiated into Schwann cells. The resulting induced Schwann cells (iSCs) expressed numerous Schwann cell-spe-
cific proteins and displayed neurosupportive andmyelination capacity in vitro. Thus,we established a strategy to obtainmature Schwann
cells from human postnatal fibroblasts under chemically defined conditions without the introduction of ectopic genes.
INTRODUCTION
In recent years, the idea of directly converting one somatic
cell type into another has attracted substantial attention
because it offers a valuable source for cells that are difficult
to access (Vierbuchen andWernig, 2011). However, amajor
drawback linked to current strategies is the fact that they
are based on ectopic expression of key developmental
genes that often have to be stably integrated into the
genome. Despite the possibilities to tightly control ectopic
gene expression, such genetic modifications may have
undesired effects. Small molecules specifically modifying
key signaling pathways provide a powerful tool to
enhance conversion or even replace reprogramming genes.
Recently, the generation of pluripotent stem cells in mouse
by small molecules has been reported (Hou et al., 2013).
However, chemical conversion of human cells has thus
far only been demonstrated for the generation of endo-
dermal cells (Pennarossa et al., 2013).
Here, we aimed to convert human fibroblasts into
Schwann cells, the major glial cell type of the peripheral
nervous system.
Using a multikinase inhibitor, we attempted to convert
fibroblasts first into a transient precursor stage showing
features of neural crest, the origin of Schwann cells. These
transient precursors were then further differentiated into
mature Schwann cells. Importantly, the complete cell con-
version process did not require the expression of ectopic
genes but was solely based on chemical treatment. It thus
represents a promising approach to generate patient-spe-
cific Schwann cells and proves that cellular identities can
be significantly altered by small molecule treatment.
RESULTS
Identification of a Compound Allowing Neural
Transdifferentiation
Current protocols for converting one cell type into another
often suffer from low efficiencies (Table S1 available
online). This might be partially due to the fact that many
protocols attempt to obtain postmitotic cell types, e.g.,
neurons. Thus, the conversion procedure includes a stop
of proliferation, which reduces both yield and efficiency.
To maximize these parameters, we established a two-step
protocol for fibroblast transdifferentiation. First, fibroblasts
are converted into a transient, proliferative neural precur-
sor stage. In a second step, these precursors are differenti-
ated into induced Schwann cells (iSCs).
In vivo, Schwann cells arise from the neural crest (NC), a
multipotent, neuroepithelial cell population that is speci-
fied by numerous signaling cues (Stuhlmiller and Garcı´a-
Castro, 2012). We reasoned that the combination of neural
inductive cues together with NC specifiers might induce a
NC fate in fibroblasts. As potent neural inducing signal
we used a small molecule—compound B (CB)—that had
been identified in a high-throughput screen to selectively
promote proliferation of neural stem cells while inhibiting
their differentiation (Figures 1A–1C). Induction of a prolif-
erative precursor stage in fibroblasts was analyzed by the
capacity of sphere formation, an assay widely used to iden-
tify cells with progenitor features (Dontu et al., 2003;
Tropepe et al., 2000). CB treatment resulted in a significant
increase in both sphere size and total cell number (Fig-
ure 1D) compared to control-treated cells. Kinase profiling
identified CB as potent multikinase inhibitor with the
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Figure 1. Identification of a Small Molecule Enhancing Neural Stem Cell Proliferation and Enabling Conversion of Fibroblasts into
Neurosphere-like Structures
(A) Structure of compound B (CB).
(B) CB selectively promotes proliferation of ESC-NSCs. Proliferation was analyzed by ATP assay. Fold increase to control-treated cells
is shown. Left: dose-response assay with ESC-NSCs (n = 4). Right: effect of CB (0.5 mM) on proliferation of ESC-NSCs (n = 4) and ESC-MSCs
(n = 2).
(C) CB inhibits differentiation of ESC-NSCs in a dose-dependent manner. Left: immunostaining of TUJ1 of NSCs treated for 7 days with DMSO
(control) or CB at various concentrations. Scale bar, 100 mm. Right: quantification of total length of neurite network upon CB treatment for
7 days. Values are normalized to control-treated cells (n = 3).
(D) CB (2 mM)-treated fibroblasts form sphere-like structures in suspension. Scale bars, 200 mm.
(E) Kinase selectivity profiling of CB. Orange bars represent kinases inhibited more than 80% at 1 mM.
(F) Single or combined inhibition of CB target kinases by other compounds (targets in parentheses) has no or smaller effect on sphere
formation. Graphs show proliferation rate as fold change of initial cell number (left) and mean sphere diameter (right) at day 3 of
suspension culture (n = 3). *p < 0.05 compared to DMSO control. +, p < 0.05 for CB compared to single inhibitors.
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major targets AMPK, PKA, MSK1, SGK1, ROCK2, and PKGa
(Figure 1E). Single inhibitors of these kinases or combina-
tions of inhibitors did not induce similar increase in sphere
size and cell number as CB (Figure 1F). However, com-
pounds H89 and Y27632, both inhibiting ROCK2, also
induced a significant increase in sphere diameter compared
to control-treated cells but did not induce an increase in
proliferation rate. Thus, the effects of CB on sphere forma-
tion and cell proliferation apparently depend on the inhi-
bition of a combination of distinct signaling pathways.
Conversion of Fibroblasts into Transient Neural
Precursors
Based on sphere formation as initial step, we established
an optimized protocol to induce a transient precursor (tP)
phenotype in postnatal fibroblasts (Figure 2A) tested nega-
tive for neural crest and Schwann cell markers (Figures
S1A–S1C). First, fibroblasts were treated with the histone
deacetylase (HDAC) inhibitor valproic acid (VPA). VPA is
known to enhance reprogramming and transdifferentia-
tion processes (Huangfu et al., 2008; Tursun et al., 2011)
and increased the effect of CB on sphere size in our protocol
(Figure 2B). VPA treatment was followed by induction of a
neural precursor fate by CB treatment in neural stem cell
medium. The resulting cells were expanded and addition-
ally treated with synergistic inhibitors of BMP (Noggin),
TGF-b (SB431542), and GSK3b (CP21, Roche Compound)
signaling. This strategy is known to enhance gene-trans-
fer-dependent neural conversion of fibroblasts (Ladewig
et al., 2012). Then, spheres were plated on polyornithine-
laminin (POL) and transferred to differentiation medium.
Sphere attachment was observed within 2 hr after plating,
and cells soon started tomigrate out of spheres. In contrast,
if spheres had been generated using inhibitors of single CB
targets, sphere attachment was highly impaired and no or
only poor migration of cells was observed (Figure S2).
During physiological NC development, laminin represents
one of the key ECM components mediating migration and
survival of NC cells (Bronner-Fraser, 1986; Desban et al.,
2006). Thus, the capacity to attach rapidly and migrate
on laminin indicates that CB-treated cells have adopted
some NC features.
Twenty-four hours after attachment, cells stained posi-
tive for neuroepithelial markers SOX1 and NESTIN but
did not express neural crest markers. No expression of
SOX2 was observed indicating the absence of neural
stem cells (Figure 2C). One week later (d18), cells expressed
neural crest markers CD271, SNAI1, SOX10, FOXD3, and
PAX3 suggesting they had adopted some features of NC
cells (Figures 2D and 2E). Loss of fibroblast identity was
indicated by downregulation of the fibroblast surface
marker CD29 (Figure 2E). When cultured in specific differ-
entiation media, tPs formed adipocytes, smooth muscle
cells, and chondrocytes suggesting a multipotent differen-
tiation capacity (Figures 2F–2H). To exclude the possibility
that the induced tPs originated from rare mesenchymal
stem cells (MSCs) in the initial fibroblasts, we tested
both fibroblasts and tPs for expression of the MSC marker
CD146 (Halfon et al., 2011). No CD146-positive cells were
detected in the initial fibroblast population or in tPs (Fig-
ures S1D and S1E).
Differentiation into Induced Schwann Cells
To induce Schwann cell formation, tPs were cultured in
differentiation medium for 3–4 weeks. After an initial pro-
liferation phase during the tP stage, cell numbers decreased
about 50% and then remained constant until the end of
the experiment (Figure S3A). After 4 weeks, cells expressed
Schwann cell markers PLP, EGR2 (also known as KROX20),
S100B, GALC, and GFAP (Figures 3A–3E, S3B, and S3C)
(Bhatheja and Field, 2006; Jessen andMirsky, 2005). Quan-
tification of cells expressing the Schwann cell marker PLP
(Griffiths et al., 1995; Kamholz et al., 1992) revealed that
more than 60% of cells had transdifferentiated into
induced Schwann cells (iSCs) (Figure 3E). Cells stained
negative for the fibroblast marker HMMR and the neuron
marker MAP2 indicating the absence of fibroblast and neu-
rons, respectively (Figures S3D and S3E).
To analyze the conversion process on themolecular level,
genome-wide gene expression profiling was performed at
different time points andwith primary Schwann cells. Prin-
cipal component analysis (PCA) revealed a clear difference
between fibroblasts and tPs on the one hand and primary
and induced Schwann cells on the other hand, which are
more similar to each other than to fibroblasts (Figure 3F).
This similarity of primary to induced Schwann cells is
also reflected by the high Pearson correlation coefficient
for all expressed genes (r = 0.93). Gene set enrichment
analysis (GSEA) revealed significant upregulation of
several biological processes corresponding to Schwann
cell functions like extracellular matrix organization,
NCAM signaling for neurite outgrowth, Notch signaling,
or immune response signaling pathways (Figure 3G; Table
S2) (Kidd et al., 2013). These networks were also activated
in primary Schwann cells further supporting the Schwann
cell identity of iSCs (Table S2). In addition, gene expression
profiling showed that iSCs produced several neurotrophic
factors for neuronal survival, regeneration, and axonal
outgrowth (Figure S3H) (Raivich and Makwana, 2007).
Gene sets associated with mitotic cell division were down-
regulated, which is consistent with the transition frompro-
liferative fibroblasts and precursors into postmitotic
Schwann cells (Figures 3G and S3G; Table S2).
It has been shown that so-called skin-derived precursors
(Toma et al., 2005) show NC stem cell properties and can
give rise to Schwann cells (Fernandes et al., 2004;McKenzie
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Figure 2. Conversion of Human Fibroblasts into a Transient Neural Precursor Stage
(A) Scheme of experimental setup for conversion into induced Schwann cells.
(B) Pretreatment with valproic acid (VPA) results in increased sphere size. Columns showmean sphere diameter ± SD at day 3 of suspension
culture (n = 4).
(C) Secondary spheres at day 11 with bipolar cells growing out of spheres. Cells express neural plate markers SOX1 and NESTIN (top left). No
expression of NSC marker SOX2 and of neural crest markers SNAI1, SOX10, FOXD3, and PAX3 was detected. Scale bars, 50 mm.
(D) At day 18, cells express neural crest markers SNAI1, SOX10, FOXD3, and PAX3. Scale bars, 20 mm.
(E) Flow cytometry of precursors (d18) and fibroblasts (d0) revealed downregulation of fibroblast marker CD29 and upregulation of neural
crest marker CD271. Panels show quantification of mean fluorescence intensity (MFI) (n = 3).
(F–H) Nonneural differentiation of transient precursors. (F) Adipocyte formation analyzed by oil red O staining. (G) Formation of SMA+
smooth muscle cells. (H) Formation of chondrocytes analyzed by Alcian blue staining. Inset shows closeup of chondrogenic pellet. Scale
bars, 50 (F), 100 (G), and 20 mm (H, inset).
See also Figure S1 and S2.
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et al., 2006). To exclude that iSCs originated from skin-
derived precursors, depletion of CD271-positive cells was
performed in the initial fibroblast population using
MACS. CD271-depleted fibroblasts converted into tPs and
further into iSCs with no difference in time course or effi-
ciency compared to unsorted fibroblasts (Figures S3I–
S3Q). These results suggest that indeed iSCs originated
fromfibroblasts that converted toward another phenotype,
albeit the possibility that rare skin-derived precursors
differentiated into Schwann cells cannot be completely
excluded.
Functional Features of Induced Schwann Cells
To analyze iSC functionality, we first tested excitability
of iSCs performing whole patch-clamp recordings. Brief
depolarizing current pulses of increasing intensity did not
evoke action potentials. However, upon 100 ms voltage-
step pulses from70 to +40mV in 10mV steps increments,
a sustained outward current component was observed indi-
cating the presence of voltage-dependent K+ channels, a
known feature of Schwann cells (Baker, 2002). K+ currents
were significantly larger in iSCs compared to untreated
fibroblasts (Figures 3H, 3I, and S3F).
Figure 3. Differentiation of Transient Precursors into Induced Schwann Cells
(A–D) iSCs express Schwann cell markers. Scale bars, 50 mm.
(E) Quantification of PLP-positive cells at d31. Few PLP-positive fibroblasts are due to background signal (n = 3).
(F) Principal component analysis of whole-transcriptome expression profiles from fibroblasts (d0), transdifferentiated cells at d7
(early tP), d11 (early tP), d18 (late tP), d39 (iSCs), and primary Schwann cells (pSCs). Principal component 1 (x axis) accounts for 27.4%
and principal component 2 (y axis) accounts for 16.5% of the variation of the data set. Each stage is represented by at least two data points
derived from independent experiments. The clustered transcriptomic profiles at day 39 suggest the robustness of the protocol.
(G) Enrichment map of gene sets for cellular signaling pathways (Reactome/NCI Nature PID) derived from GSEA comparing iSCs (d39) with
fibroblasts (d0). Red nodes represent gene sets enriched in iSCs, whereas blue nodes represent gene sets enriched in fibroblasts. Nodes are
grouped and annotated by their similarity according to related gene sets. Cluster of functionally related nodes were summarized and
annotated using WordCloud (n = 3).
(H) Whole patch-clamp analysis of iSCs. Voltage-dependent current obtained from a –70 to +40 mV in 10 mV increasing steps protocol from
a holding potential Vh =80 mV. Absence of early inward current confirms the deficiency of voltage-dependent Na+ channels, whereas the
outward component is consistent with the presence of voltage-dependent K+ channels.
(I) Maximal voltage-dependent K+ currents are significantly higher in iSCs than in fibroblasts. Columns show means ± SD of different cells
(FBs: n = 12; iSCs: n = 7) measured in two independent experiments.
See also Figure S3 and Table S2.
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To analyze neuroprotective functionality of iSCs, cells
were cocultured with neurons differentiated from human
embryonic stem cell (ESC)-derived neural stem cells
(NSC-neurons). As control, NSC-neurons were plated on
POL or untreated fibroblasts. NSC-neurons plated on fibro-
blasts aggregated in dense clusters whereas cocultured iSCs
and NSC-neurons formed a dense, multicellular network
(Figures 4A and S4). MAP2 staining confirmed that NSC-
neurons cultured with iSCs formed a more branched neu-
rite network than NSC-neurons grown alone or with fibro-
blasts (Figure 4B). Moreover, total number of neurons was
also increased in coculture with iSCs (Figure S4J). These re-
sults suggest that iSCs are capable to enhance neuronal sur-
vival, differentiation, and neurite network formation.
To test if iSCs are capable of myelination, iSCs were
cocultured with primary rat dorsal root ganglia neurons
(DRGs). After 3 weeks, myelinated axon segments could
be observed further confirming the functionality of iSCs
(Figure 4C). The low frequency of myelinated fragments
(five to ten fragments/96 well) might be due to species dif-
ferences between iSCs and neurons. This observation is in
line with previous studies showing that human Schwann
cells had a markedly reduced efficacy to myelinate rat sen-
sory neurons compared to primary rat Schwann cells
(Lehmann et al., 2012).
DISCUSSION
In recent years, numerous studies reporting reprogram-
ming or transdifferentiation of somatic cells have shown
that even in terminally differentiated cells fate plasticity
can be evoked and that transition to other cell types,
even across germ-layer boundaries, is still possible.
Here, we present an approach to transdifferentiate
human fibroblasts via a transient precursor stage into
Schwann cells that does not depend on ectopic gene
expression but is based on chemical modification of
defined signaling pathways. Such gene-free, chemical-
based conversion strategies allow the generation of cells
without genetic modifications and furthermore can be
very tightly controlled by altering concentrations or dura-
tion of small molecule treatment.
In our approach, conversion to Schwann cells was
induced by sequential treatment with defined compounds.
First, a brief VPA treatment step probably resulted in an
Figure 4. Functionality of iSCs in Cocul-
ture with Neuronal Cells
(A) Culture of NSC-derived neurons alone, on
cell tracker-labeled fibroblasts and iSCs,
respectively. Scale bars, 100 mm.
(B) NSC-neurons cultured with iSCs form a
more dense and branched network analyzed
by MAP2-stained area, neurite number, and
total neurite length (n = 3). *p < 0.05.
(C) Coculture of iSCs with primary rat DRG
neurons. Some iSCs form single myelinated
fragments (arrowhead) detected by coloc-
alization of MBP staining (yellow) and
neurofilament (NF) staining (magenta).
Scale bars, 20 mm.
See also Figure S4.
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erase of epigenetic signatures making cells more amenable
for cell-fate changing signals—a process that may also be
involved in gene-free iPS generation or transdifferentiation
into endodermal cells (Hou et al., 2013; Pennarossa et al.,
2013). Fate determination toward transient precursors
was achieved by treatment with CB inhibiting AMPK,
MSK1, PKA, ROCK2, PKGa, and SGK1. Several studies of
these signaling pathways allow assumptions regarding
the mechanistic regulation of the conversion process.
Because upregulation of SGK1 correlates with cell death
in neurodegenerative disease (Schoenebeck et al., 2005),
its inhibition might enhance the survival of cells that con-
verted toward a neural fate. Moreover, CB might abolish a
metabolic barrier mediated by AMPK signaling, which is
known to prevent reprogramming processes (Vazquez-Mar-
tin et al., 2012).
ROCK2 inhibition evokes a proliferative, stem cell-like
phenotype (Terunuma et al., 2010), promotes emigration
of neural crest cells (Groysman et al., 2008), and has neuro-
protective effects (Ding et al., 2009). These effects might
also support fibroblast conversion into neural precursors
and iSCs.
Additionally, our approach included small molecule-
based inhibition of TGF-b, BMP, and GSK3 signaling, a
strategy known to direct differentiation of ESCs to neuroe-
pithelial and/or neural crest fates (Chambers et al., 2009;
Menendez et al., 2011).
Altogether, this study shows as proof of principle that
conversion of fibroblasts toward a neural cell fate can
be achieved solely by small molecule treatment. We identi-
fied CB as potent compound to induce neural cell iden-
tity and developed a CB-based approach to efficiently
generate Schwann cells without any genetic modifications.
Compared to existing Schwann cell sources like derivation
from pluripotent stem cells (Liu et al., 2012) or as primary
cells (Casella et al., 1996), chemical-based conversion is
more cost effective and easier to control and to standardize.
Because Schwann cells play an important role in develop-
ment, homeostasis, and diseases of the peripheral nervous
system (Bhatheja and Field, 2006), we suggest that iSCs
could represent useful tools to analyze Schwann cell func-
tions or pathophysiology in vitro and to develop cellular
interaction models allowing to study disease mechanisms
in neuron-Schwann cell coculture.
EXPERIMENTAL PROCEDURES
Details are provided as Supplemental Experimental Procedures.
Cell Culture
SCC058 foreskin fibroblasts (Millipore) were seeded in low serum
FibroGro (Millipore) containing 1 mM Valproic acid (VPA, Sigma).
Cells were treated for 2 dayswith 1mMVPA and 6 mg/ml polybrene
(Millipore) and subsequently transferred to low attachment plates
in NSC medium for sphere formation. After 4 days, spheres were
dissociated, and cells were seeded in low attachment plates in
NSC medium supplemented with inhibitor mix consisting
of 500 ng/ml Noggin (PeproTech), 10 mM SB431452 (Tocris
Bioscience), and 1 mM CP21 (Roche, GSK3 inhibitor, published
elsewhere). After 3 days, secondary spheres were seeded on polyor-
nithine-laminin (POL)-coated dishes. After attachment (24 hr),
medium was replaced with neural differentiation medium. Every
other day, 50% of medium was exchanged. For the first 7 days of
differentiation, medium was supplemented with inhibitor mix.
MACS depletion of CD271-positive cells from the initial fibroblasts
was performed using a CD271 Microbead kit (Miltenyi).
For adipocyte and smooth muscle cell differentiation, secondary
spheres were plated on growth factor reduced matrigel. After 24 hr,
mediumwaschanged toadipocytedifferentiationmedium.Medium
was changed every other day. After 4weeks, cells were fixedwith 4%
paraformaldehyde (PFA) and stained with oil red O or anti-SMA.
For chondrogenesis, secondary spheres were cultured as pellet in
chondrocyte differentiation medium. After 4 weeks, the pellet was
fixed with 4% PFA and analyzed by Alcian blue staining.
Embryonic stem cell-derived neural stem cells (NSCs) were
generated as previously described (Chambers et al., 2009). NSCs
were cultured on POL in N2B27 supplemented with basic
fibroblast growth factor (10 ng/ml), epidermal growth factor
(10 ng/ml), and brain derived neurotrophic factor (20 ng/ml).
For iSC/NSC neuron coculture, NSCs were cultured in differenti-
ation medium for 13 days and then seeded in differentiation me-
dium on POL only, fibroblasts, or iSCs at 120,000 NSC-neurons/
12 well. Fibroblasts and iSCs had been previously labeled with
CFSE cell tracker (Invitrogen, 10 mM for 20 min). Every other
day, 50% of medium was exchanged. Cells were fixed with 4%
PFA at day 13 of coculture.
For iSC/rat DRG coculture, embryonic rat DRG neurons (Lonza)
were seeded on poly-D-Lysine-laminin-coated plates and cultured
at 37C, 5% CO2 in PNGM medium (Lonza) supplemented with
100 ng/ml NGF (PeproTech). To eliminate rat glial cells, cultures
were treated with 17.5 mg/ml uridine and 7.5 mg/ml 5-fluoro-
2-deoxyuridine (both Sigma) for at least 7 days. Then, iSCs
(day 21) were seeded onDRG cultures at 30,000 cells/cm2. Cultures
weremaintained in PNGMmedium supplementedwith 100ng/ml
NGF with 50% medium exchange every other day. At day 4 of
coculture, myelination was induced by adding 50 mg/ml ascorbic
acid to the medium.
Human primary Schwann cells (Sciencell) were cultured on poly-
L-lysine coated dishes in Schwann cell medium (Sciencell).
Kinase Selectivity Profiling
Kinase selectivity profiling was performed using ProfilerPro Kinase
Kits from Caliper (PerkinElmer) according to the manufacturer’s
instructions.
Genome-wide Gene Expression Analysis
RNA samples were processed for microarray expression profiling
using the Affymetrix HG-U133_plus_2 platform. Data analysis
was performed using Partek Genomics Suite 6.6 (Partek) and
Gene Set Enrichment Analysis.
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Statistics
Data are presented as mean ± SD. Statistical significance was tested
with Student’s t test. The number of independent experiments is
given as ‘‘n.’’
ACCESSION NUMBERS
Themicroarray data have been deposited at theNCBIGene Expres-
sion Omnibus (GEO) under the accession number GSE59125.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.07.014.
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